Identification of potential influenza virus endonuclease inhibitors through virtual screening based on the 3D-QSAR model

SAR and QSAR in Environmental Research

Volumn 20, Issue 1-2, 2009, Pages 103-118

  Kim, J ^a   Lee, C ^a   Chong, Y ^a  

^a Konkuk University   (South Korea)

Author keywords

3D QSAR; CoMSIA; Influenza virus endonuclease; Virtual screening

Indexed keywords

COMPUTATIONAL CHEMISTRY; DIGITAL LIBRARIES; HYDROPHOBICITY; MOLECULAR GRAPHICS; PHARMACODYNAMICS; VIRUSES;

3D-QSAR; ANTIVIRAL THERAPY; COMPARATIVE-MOLECULAR-SIMILARITY-INDICES ANALYSIS; ENDONUCLEASE INHIBITORS; ENDONUCLEASES; INFLUENZA VIRUS; INFLUENZA VIRUS ENDONUCLEASE; PHARMACOPHORES; QSAR MODEL; VIRTUAL SCREENING;

ANTIVIRAL AGENTS;

ORTHOMYXOVIRIDAE;

ANTIVIRUS AGENT; DESIGNER DRUG; ENDONUCLEASE; ENZYME INHIBITOR; VIRUS PROTEIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; FORECASTING; HUMAN; METHODOLOGY; ORTHOMYXOVIRUS; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANTIVIRAL AGENTS; DESIGNER DRUGS; ENDONUCLEASES; ENZYME INHIBITORS; FORECASTING; HUMANS; MODELS, MOLECULAR; ORTHOMYXOVIRIDAE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL PROTEINS;

EID: 67650924232     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/10629360902723962     Document Type: Article

References (21)

1. W.P. Glezen, Serious morbidity and mortality associated with influenza epidemics, Epidemiol. Rev. 4 (1982), pp. 25-44.
2. D.M. Perrotta and W.P. Glezen, Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza, Am. J. Epidemiol. 122 (1985), pp. 468-476.
3. R.G. Douglas Jr, Prophylaxis and treatment of influenza, N. Engl. J. Med. 322 (1990), pp. 443-450.
4. F.G. Hayden and A.J. Hay, Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine, Curr. Top. Microbiol. Immunol. 176 (1992), pp. 199-130.
5. J. Tomassini, H. Selnick, M.E. Davies, M.E. Armstrong, J. Baldwin, M. Bourgeois, J. Hastings, D. Hazuda, J. Lewis, W. McClements, G. Ponticello, E. Radzilowski, G. Smith, A. Tebben, and A. Wolfe, Inhibition of Cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substitutued 2,4-dioxobutanoic acid compounds, Antimicrob. Agents Chemother. 38 (1994), pp. 2827-2837.
6. J.C. Hastings, H. Selnick, B. Wolanski, and J.E. Tomassini, Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors, Antimicrob. Agents Chemother. 40 (1996), pp. 1304-1307.
7. O.D. Hensens, M.A. Goetz, J.M. Liesch, D.L. Zink, S.L. Raghoobar, G.L. Helms, and S.B. Singh, Isolation and structure of flutimide, a novel endonuclease inhibitor of influenza virus, Tetrahedron Lett. 36 (1995), pp. 2005-2008.
8. S.B. Singh, Total synthesis of flutimide, a novel endonuclease inhibitor of influenza virus, Tetrahedron Lett. 36 (1995), pp. 2009-2012.
9. S.B. Singh and J.E. Tomassini, Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus, J. Org. Chem. 66 (2001), pp. 5504-5516.
10. J.E. Tomassini, M.E. Davies, J.C. Hastings, R. Lingham, M. Mojena, S.L. Raghoobar, S.B. Singh, J.S. Tkacz, and M.A. Goetz, A novel antiviral agent which inhibits the endonuclease of influenza viruses, Antimicrob. Agents Chemother. 40 (1996), pp. 1189-1193.
11. C. Cianci, T.D.Y. Chung, N. Meanwell, H. Putz, M. Hagen, R.J. Colonno, and M. Krystal, Identification of N-hydroxamic acid and N-hydroxyimide compounds that inhibit the influenza virus polymerase, Antiviral Chem. Chemother. 7 (1996), pp. 353-360.
12. K.E. Parkes, P. Ermert, J. Fässler, J. Ives, J.A. Martin, J.H. Merrett, D. Obrecht, G. Williams, and K. Klumpp, Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors, J. Med. Chem. 46 (2003), pp. 1153-1164.
13. Y. Furuta, K. Takahashi, Y. Fukuda, M. Kuno, T. Kamiyama, K. Kozaki, N. Nomura, H. Egawa, S. Minami, Y. Watanabe, H. Narita, and K. Shiraki, Antimicrob, In vitro and in vivo activities of anti-influenza virus compound T-705, Antimicrob. Agents Chemother. 46 (2002), pp. 997-981.
14. Tripos Inc. SYBYL 7.2 (2002).
15. M. Mohammadi, G. McMahon, L. Sun, C. Tang, P. Hirth, B.K. Yeh, S.R. Hubbard, and J. Schlessinger, Structure of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors, Science 276 (1997), pp. 955-960.
16. J. Gasteiger and M. Marsili, Iterative partial equalization of orbital electronegativity: a rapid access to atomic charges, Tetrahedron 36 (1980), pp. 3219-3222.
17. R.D. Cramer III, D.E. Patterson, and J.D. Bunce, Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc. 110 (1988), pp. 5959-5967.
18. G. Klebe, U. Abraham, and T. Mietzner, Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity, J. Med. Chem. 37 (1994), pp. 4130-4146.
19. R.D. Clark, OptiSim: An extended dissimilarity selection method for finding diverse representative subsets, J. Chem. Inf. Comput. Sci. 37 (1997), pp. 1181-1188.
20. S.L. Dixon and R.T. Koehler, The hidden component of size in two-dimensional fragment descriptors: Side effects on sampling in bioactive libraries, J. Med. Chem. 42 (1999), pp. 2887-2900.
21. L. Doan, B. Handa, N.A. Roberts, and K. Klumpp, Metal ion catalysis of RNA cleavage by the influenza virus endonuclease, Biochemistry 38 (1999), pp. 5612-5619.